4.5 Article Proceedings Paper

The reliability of skin biopsy with measurement of intraepidermal nerve fiber density

Journal

JOURNAL OF THE NEUROLOGICAL SCIENCES
Volume 228, Issue 1, Pages 65-69

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jns.2004.09.032

Keywords

skin biopsy; reproducibility; neuropathy; small fiber

Funding

  1. NCRR NIH HHS [M01-RR00064] Funding Source: Medline
  2. NIDDK NIH HHS [DK064814] Funding Source: Medline
  3. NINDS NIH HHS [NS44807, NS40458, NS 43011] Funding Source: Medline

Ask authors/readers for more resources

Intraepidermal nerve fiber density (IENFD) is a sensitive measure of small fiber injury, and holds promise as a clinical trial tridpoint measure. A total of 48 punch biopsies were obtained from 22 patients. Tissue was sectioned and stained with PGP9.5. The relative internal variability (RIV) of IENFD measurements for each section and punch made by two different observers was determined (interobserver variability). Intraobserver variability (same observer measuring twice) was determined for 50% of the sections and punches. Section front 12 punch biopsies were also stained at a second laboratory. The effect of the number of sections counted and processing site on reproducibility as investigated. A total of 223 sections were analyzed. The mean IENFD was 6.7 fibers/mm. Mean (+/- standard deviation) interobserver variability was 9.6% +/- 9.4 for each biopsy site and 10.2% + 11.9 for individual sections. Mean intraobserver variability was 9.6% +/- 8.9 for biopsies, and 8.8% +/- 9.0 for sections. There was no significant difference in IENFD for tissue stained at different laboratories. Intraclass correlation coefficients were greater than 0.98 for each comparison. There was no relation-ship between absolute IENFD and reproducibility. Reproducibility was highest when four sections were counted. IENFD measurement is highly reproducible. At least four sections should be analyzed. Reliability does not vary, with severity of disease. These findings suggest IENFD may be a useful endpoint measure in future neuropathy treatment trials. (C) 2004 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available